Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.30, Iss.1, 2012-01, pp. : 35-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PALLAS: limiting indications for dronedarone treatment of atrial fibrillation?

By Doggrell Sheila A Hancox Jules C

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 6, 2012-04 ,pp. : 867-871

Informa Healthcare

Access to resources Recommend Favorite

Golimumab for the Treatment of Psoriatic Arthritis: A NICE Single Technology Appraisal

By Yang Huiqin

PharmacoEconomics, Vol. 30, Iss. 4, 2012-04 ,pp. : 257-270

Adis International

Access to resources Recommend Favorite

Dronedarone rates highly for atrial fibrillation

Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6-11 Years: A NICE Single Technology Appraisal

By Burch Jane

PharmacoEconomics, Vol. 30, Iss. 11, 2012-11 ,pp. : 991-1004

Adis International

Access to resources Recommend Favorite

Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal

By Boyers Dwayne

PharmacoEconomics, Vol. 30, Iss. 6, 2012-06 ,pp. : 483-495

Adis International

Access to resources Recommend Favorite